ABVX Stock Analysis: Buy, Sell, or Hold?
ABVX - Abivax SA American Depositary Shares
$134.09
2.59 (1.97%)
▲
5d:
-0.61%
30d:
+35.24%
90d:
+16.62%
BUY
MODERATE Confidence
Analysis Updated: Jul 21, 2026 12:00 AM ET
Earnings: Sep 21, 2026
Get Alerted When ABVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ABVX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ABVX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ABVX is currently trading at $134.09, which is considered slightly high relative to its 30-day fair value range of $98.93 to $139.78.
Technical Outlook: Technically, ABVX is in a strong uptrend. The price is currently testing key support at $130.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $161.00 (+20.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABVX is in a strong uptrend. The price is currently testing key support at $130.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $161.00 (+20.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$98.93 -
$139.78
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.1% below Wall St target ($161.00)
Trading Range Analysis
30-Day Trading Range
$98.93 -
$139.78
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$130.86
Resistance Level
$141.75
Current Trend
Strong Uptrend
Technical data as of
Jul 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-41.08
Wall Street Target
$161.00
(+20.1%)
Revenue Growth (YoY)
35.2%
Share & Embed Analysis
Last updated: July 21, 2026 5:42 PM ET
Data refreshes hourly during market hours. Next update: 6:42 PM
Data refreshes hourly during market hours. Next update: 6:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABVX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$86 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$554 | 48 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 45 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 55 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 49 HOLD |
